|
ACD/Labs and Metabometrix Announce Collaboration
February 24th 2003
The application of Nuclear Magnetic Resonance to the study of biofluids
is one of the primary activities presently underway in the field of
metabonomics. One of the key innovators in this area is Metabometrix. ACD/Labs and Metabometrix today
announce the intention to provide access to assigned databases of NMR
spectra of biofluids using ACD/NMR Manager as the delivery tool.
Scientists at Metabometrix have been working closely with ACD/Labs to
test new NMR phasing and baseline correction routines applicable to the
spectra of biofluids and tolerant of the many associated issues. "Our
interactions with the scientists at Metabometrix have enabled us to
develop the most capable processing algorithms in desktop NMR software
available today," comments Antony Williams, VP of Scientific Development
and Marketing for ACD/Labs. "ACD/Labs software has made it possible for
us to fully automate our spectral processing and still achieve excellent
results," comments John Shockcor, Director of Physical and Analytical
Sciences, Metabometrix. "We look forward to delivering databases
applicable to the study of metabonomics and other biochemical
applications compatible with ACD/NMR Manager software by Spring 2003."
|
